Dharti Proteins Ltd to consider unaudited Q1 FY2026 results at board meeting on July 15

What Dharti Proteins Ltd announced

Dharti Proteins Ltd filed a board‑meeting intimation with BSE on 10 July 2026, stating that the Board of Directors will convene on 15 July 2026. The primary agenda is to consider and approve the unaudited financial results for the quarter ended 30 June 2026, together with the accompanying Limited Review Report.

Board meeting details

• Date of meeting: 15 July 2026 (Wednesday)
• Filing date: 10 July 2026 (UTC 04:48)
• Venue/format: Not specified in the filing; standard practice is a physical or virtual meeting as per the company’s Articles of Association.
• Agenda items:
  1. Presentation of unaudited financial statements for Q1 FY2026.
  2. Review of the Limited Review Report prepared by the auditors.
  3. Any other business as may be raised by the directors.

The filing does not disclose any other agenda items, nor does it provide details on the composition of the meeting (e.g., presence of independent directors).

Unaudited financial results – what is known

The announcement merely confirms that the Board will examine the unaudited results for the quarter ending 30 June 2026. No quantitative data—such as revenue, profit, or margin figures—are included in the intimation. The Limited Review Report, which is typically a condensed audit opinion, will also be presented, but its conclusions are not disclosed.

"The Board will consider and approve the Unaudited Financial Results for the quarter ended June 30, 2026 along with Limited Review Report thereon." – Board meeting intimation, 10 July 2026.

Investors will need to await the formal release of the results, which is usually published shortly after the Board’s approval.

Key facts at a glance

Why this matters for investors

The approval of unaudited results is a routine corporate governance step, but it signals when the company’s quarterly performance will become publicly available. Once approved, the results are typically disseminated to shareholders and the market, allowing investors to assess the company’s operational health for the quarter. The filing does not indicate any material changes, restructuring, or extraordinary items that would affect the company’s financial position.

Conclusion

Dharti Proteins Ltd has formally announced a board meeting on 15 July 2026 to approve its unaudited financial results for the quarter ended 30 June 2026. No financial numbers are disclosed in the intimation, and investors will need to wait for the post‑meeting release of the results and the Limited Review Report to gauge the company’s performance.